Orchestra BioMed Holdings, Inc. (OBIO) vs Ocugen, Inc. (OCGN)

A side-by-side comparison of Orchestra BioMed Holdings, Inc. and Ocugen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — OBIO vs OCGN

growth of $100 · dividends reinvested · last 6y
OBIO -47.1% (-10.1%/yr)OCGN +96.2% (+11.9%/yr)OCGN compounded faster over this window
01k2kStart $100202120222023202420252026$53$196
OBIO OCGN

OBIO vs OCGN: by the numbers

  • •OCGN is the larger company ($356M vs $353M market cap).
  • •Both run net losses; OBIO's is the smaller (-184.60% vs -1786.27% net margin).

Metrics side by side

Valuation

MetricOBIOOCGN
P/S ratio11.0477.74
P/B ratio18.27N/A

Profitability

MetricOBIOOCGN
Gross margin99.32%45.86%
Operating margin-154.73%-1425.70%
Net margin-184.60%-1786.27%
ROE-200.64%N/A
ROIC-56.73%-93.74%

Growth (annualized)

MetricOBIOOCGN
Revenue CAGR (5Y)148.45%N/A
Total return CAGR (5Y)-9.35%-31.57%

Frequently asked

How have OBIO and OCGN total returns compared?
Over the past 5 years, OBIO delivered -9.35% and OCGN delivered -31.57% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.